Reducing Inflammation to Improve Vascular and Bone Outcomes With Low-dose Colchicine in CKD | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Reducing Inflammation to Improve Vascular and Bone Outcomes With Low-dose Colchicine in CKD	Arterial Occlusive Diseases, Bone Diseases, Metabolic, Chronic Disease, Disease Attributes, Dyslipidemias, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lipid Metabolism Disorders, Male Urogenital Diseases, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, Vascular Calcification, arteriosclerosis disorder, atherosclerosis, bone disorder, calcinosis, calcium metabolic disease, cardiovascular disorder, chronic renal failure syndrome, diabetes mellitus, endocrine system disorder, glucose metabolism disease, hyperparathyroidism, hypertensive disorder, kidney disorder, kidney failure, metabolic disease, musculoskeletal system disorder, nutritional deficiency disease, nutritional disorder, parathyroid gland disorder, renal osteodystrophy, rickets, secondary hyperparathyroidism, urinary system disorder, vascular disorder, vitamin D deficiency, vitamin deficiency disorder	Not yet recruiting	Phase 2	2026-06-22		NCT07654231

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
University of Texas Southwestern Medical Center	295

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
University of Texas Southwestern Medical Center	Dallas	United States	249